Clinical Trials Logo

Clinical Trial Summary

Although much investigation has been done on the use of ferning in the second and third trimesters, particularly with the development of rapid protein clinical assays, there appears to be lower ferning rates in clinical practice with traditional techniques compared to previous published research on the subject. Much of the older study designs are lacking in detail and lack a large enough sample sizes at each gestational age to appropriately interpret the significance of ferning results by gestational age. Additionally, a large premise for the current tests used to diagnose rupture of membranes is based on these older studies. Given this, we propose collecting amniotic fluid vaginally to evaluate for the presence of ferning in the second trimester to determine if there is a difference in ferning based on gestational age as well as the time interval after rupture of membranes in which ferning can observed on microscope examination.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04963465
Study type Observational
Source Albany Medical College
Contact OBGYN Research Director
Phone 518-262-4942
Email Obgynresearch@amc.edu
Status Recruiting
Phase
Start date September 17, 2021
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT04294069 - Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial Phase 4
Recruiting NCT03976063 - Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation Phase 3
Completed NCT01503606 - Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane Phase 3
Recruiting NCT04590677 - Prediction of the Onset of Term and Preterm Labour
Recruiting NCT04110704 - Cerclage After Full Dilatation Caesarean Section N/A
Completed NCT03473210 - The Value of Amniopatch in Preterm Premature Rupture of Membranes N/A
Not yet recruiting NCT05328817 - Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes N/A
Recruiting NCT05353153 - The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support N/A
Completed NCT03814278 - Bed Rest After Preterm Premature Rupture of the Membranes N/A
Completed NCT04807543 - Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes Phase 2
Recruiting NCT06443788 - Trans-perineal Ultrasound in Assessment of PPROMs N/A
Not yet recruiting NCT05207800 - Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes
Recruiting NCT04705935 - Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
Not yet recruiting NCT06396078 - Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT) Phase 4
Active, not recruiting NCT06074601 - MIRACLE of LIFE Study
Recruiting NCT04516226 - Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes N/A
Recruiting NCT03306719 - mtDNA as Novel Biomarker for Intra-amniotic Infection N/A
Not yet recruiting NCT06377397 - Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates Phase 3
Completed NCT04413019 - Domiciliary Versus Hospital Management of PPROM